OpGen, Inc. Stock

$4.70

3.29% yesterday

Nasdaq, Jun 27, 09:50 pm CET

ISIN

US68373L2088

Symbol

OPGN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

OpGen, Inc. Stock price

$4.70

-403.30 98.85% 5Y

Nasdaq, Closing price Fri, Jun 27 2025

-0.16 3.29%

ISIN

US68373L2088

Symbol

OPGN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Basic

Market capitalization

$47.3m

Enterprise Value

$45.7m

Net debt

$-1.6m

Cash

$1.6m

Shares outstanding

10.1m

Valuation (TTM | estimate)

P/E

negative | -

P/S

33.09 | -

EV/Sales

31.95 | -

EV/FCF

negative

P/B

15.85

Financial Health

Equity Ratio

-614.23%

Return on Equity

282.56%

ROCE

-158.16%

ROIC

-217.41%

Debt/Equity

0.00

Financials (TTM | estimate)

Revenue

$1.4m | -

EBITDA

$-7.3m | -

EBIT

$-7.7m

Net Income

$-9.6m | -

Free Cash Flow

$-6.3m

Growth (TTM | estimate)

Revenue

-53.42% | -

EBITDA

67.11% | -

EBIT

67.47%

Net Income

63.19% | -

Free Cash Flow

64.63%

Margin (TTM | estimate)

Gross

10.33%

EBITDA

-511.90% | -

EBIT

-538.23%

Net

-671.56% | -

Free Cash Flow

-440.30%

EPS

$-1.45

FCF per Share

$-0.63

Short interest

1.79%

Employees

93.00

Rev per Employee

$40.00k

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

OpGen, Inc. Stock Analysis

Unlock Scores for Free

??

6 Analysts have issued a OpGen, Inc. forecast:

3x Hold

50%

3x Sell

50%

More details on Analyst Estimates Including Price Targets

6 Analysts have issued a OpGen, Inc. forecast:

Hold

50%

Sell

50%

Analyst Estimates with Stock Price Targets

Financial data from OpGen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	1.43 1.43	53% 53% 100%
- Direct Costs	1.29 1.29	55% 55% 90%
Gross Profit	0.15 0.15	25% 25% 10%
- Selling and Administrative Expenses	7.46 7.46	41% 41% 522%
- Research and Development Expense	0.40 0.40	93% 93% 28%
EBITDA	-7.34 -7.34	67% 67% -513%
- Depreciation and Amortization	0.38 0.38	73% 73% 27%
EBIT (Operating Income) EBIT	-7.72 -7.72	67% 67% -540%
Net Profit	-9.63 -9.63	63% 63% -673%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Head office	United States
CEO	Hon Tan
Employees	93
Founded	2001
Website	opgen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now